At the “Advanced Bio Seminar” held on September 30 at the Daedeok Tech-Biz Center, AIGENDRUG introduced its latest AI-driven drug discovery tech
The Korea Drug Development Fund (KDDF) announced on the 1st that it successfully concluded the 2025 KDDF Science Conference, which was held from
Sun Kim, CEO of AIGENDRUG, delivers a presentation at CPHI KOREA held at COEX on the 26th. (Source: The Bell)The “CPHI Korea 2025” event, jointly orga
Cho Chang-yun, Principal Researcher at AIGENDRUG (pictured right), is photographed after receiving the “Good-R&D Award” in the “AI Drug Discover
[2025 Korea Innovation Company Awards] AIGENDRUGAIGENDRUG, led by CEO Sun Kim, is a biotech startup that is revolutionizing the full cycle of dr
“Drug-likeness” — the question of whether a molecule can become a viable drug — is the ultimate question in drug discovery. Yet for over 20 year
Aigendrug has been selected as a core research participant in South Korea’s ambitious "AI-Based Full-Cycle Pharmaceutical Technology Development
On May 5th, 2025, Dr. Sun Kim, CEO of AIGENDRUG, delivered an impactful presentation at the BioKOREA 2025 Open Session on AI Research Cases
On April 23th, 2025, Dr. Sun Kim, CEO of AIGENDRUG, delivered a plenary talk at the AIxBIO GLOBAL FORUM titled "How Can AI Bioinformatics Contribute t
We are pleased to announce that Dr. Sun Kim, CEO of AIGENDRUG, has been appointed as an Advisory Committee Member for the Korea Pharmaceutical and Bio
On March 14th, 2025, Dr. Sun Kim, CEO of AIGENDRUG, delivered a compelling talk titled "Cancer Drug Response Prediction Using Omics Data" at the Korea
Aigendrug CEO, Dr. Sun Kim, recently delivered an insightful presentation titled "Introduction to How Deep Learning is Used for Antibody Design,
AIGENDRUG Senior Researcher Bon-il Koo received the Minister of Health and Welfare Award (1st place) at the 2nd AI New Drug Development Competit
On October 31, AIGENDRUG's CTO, Sun Kim, gave a keynote titled "Our Strategy for Applying Artificial Intelligence Technology to New Drug Discove
Sun Kim, CTO of AIGENDRUG, presented a talk titled "Introduction to AI Technologies for Drug Discovery" at the "2024 Gangwon-Hongcheon Drug Deve
